This suggests a minimum prevalence of absolute insulin deficiency in insulin‐treated Type 2 diabetes of 3% [5/186, excluding the five subjects who were unable to provide repeat urine samples or participate in the MMTT (Fig. 1)]. This evidence concerns the gene INS and type 2 diabetes mellitus.